454 related articles for article (PubMed ID: 36982194)
1. Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID.
Tate WP; Walker MOM; Peppercorn K; Blair ALH; Edgar CD
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982194
[TBL] [Abstract][Full Text] [Related]
2. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
[TBL] [Abstract][Full Text] [Related]
3. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
Nunes JM; Kell DB; Pretorius E
Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
[TBL] [Abstract][Full Text] [Related]
5. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
Front Immunol; 2022; 13():949787. PubMed ID: 36341457
[TBL] [Abstract][Full Text] [Related]
6. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Campen CLMCV; Rowe PC; Visser FC
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
[No Abstract] [Full Text] [Related]
7. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
Retornaz F; Rebaudet S; Stavris C; Jammes Y
J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome.
Chaves-Filho AM; Braniff O; Angelova A; Deng Y; Tremblay MÈ
Brain Res Bull; 2023 Sep; 201():110702. PubMed ID: 37423295
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses.
Tate W; Walker M; Sweetman E; Helliwell A; Peppercorn K; Edgar C; Blair A; Chatterjee A
Front Neurol; 2022; 13():877772. PubMed ID: 35693009
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
[TBL] [Abstract][Full Text] [Related]
11. Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies.
Annesley SJ; Missailidis D; Heng B; Josev EK; Armstrong CW
Trends Mol Med; 2024 May; 30(5):443-458. PubMed ID: 38443223
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
Front Immunol; 2022; 13():952987. PubMed ID: 36189286
[TBL] [Abstract][Full Text] [Related]
13. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.
Komaroff AL; Lipkin WI
Trends Mol Med; 2021 Sep; 27(9):895-906. PubMed ID: 34175230
[TBL] [Abstract][Full Text] [Related]
14. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
Bested AC; Marshall LM
Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Grach SL; Seltzer J; Chon TY; Ganesh R
Mayo Clin Proc; 2023 Oct; 98(10):1544-1551. PubMed ID: 37793728
[TBL] [Abstract][Full Text] [Related]
16. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.
Sanal-Hayes NEM; Mclaughlin M; Hayes LD; Mair JL; Ormerod J; Carless D; Hilliard N; Meach R; Ingram J; Sculthorpe NF
J Transl Med; 2023 Oct; 21(1):720. PubMed ID: 37838675
[TBL] [Abstract][Full Text] [Related]
17. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
[TBL] [Abstract][Full Text] [Related]
18. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.
Wong TL; Weitzer DJ
Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925784
[No Abstract] [Full Text] [Related]
19. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
[TBL] [Abstract][Full Text] [Related]
20. Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ).
Peo LC; Wiehler K; Paulick J; Gerrer K; Leone A; Viereck A; Haegele M; Stojanov S; Warlitz C; Augustin S; Alberer M; Hattesohl DBR; Froehlich L; Scheibenbogen C; Jason LA; Mihatsch LL; Pricoco R; Behrends U
Eur J Pediatr; 2024 Mar; 183(3):1265-1276. PubMed ID: 38095713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
